Hematological Malignancies

Oncology Solutions

The Patient Journey


In 2016, 467,000 new cases of leukemia and 310,000 deaths were reported. One in 118 men will develop the disease compared with one in 194 women. The main contributors to this increase were population growth with 12 percent, population aging with 10 percent, and an increase in age-specific incidence rates with 3 percent.1
In 2016, there were 461,000 incident cases of non-Hodgkin lymphoma and 240,000 worldwide, One in 110 men and one in 161 women developed non-Hodgkin lymphoma over a lifetime.1

  • SIGNA™ Premier AIR™ IQ Edition

    Our leading, innovative 3.0T MRI system brings you uncompromised 60 cm performance in a 70 cm wide bore for advanced imaging and research.
  • Computed Tomography

    Your need for quality patient care at low dose with greater productivity and affordability is more important than ever. That’s why we design CT systems that help...

  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

  • Q.Clear

    Do you know your patient’s response score? Q.Clear delivers quantitative SUV you and your patients can trust.
  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

The latest in Oncology


1. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability,and Disability-Adjusted Life-Years for 29 Cancer Groups,1990 to 2016. A Systematic Analysis for the Global Burden of Disease Study. Christina Fitzmaurice,MD, MPH, Division of Hematology, Department of Medicine, Institute for Health Metrics and Evaluation, University of Washington, 2301 5th Ave, Ste 600, Seattle,WA 98121

JB04823XX